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Introduction: Respiratory symptoms in relationship to exercise, bronchial hyperresponsiveness
(BHR), and exercise-induced asthma (EIA) are very common in elite winter athletes. Symptom-
based screening for BHR would facilitate selection of athletes with possible EIA.
Objectives: The aim of the present study was to evaluate the diagnostic accuracy of self-reported
symptoms as predictors of BHR in an unselected population of adult elite cross-country skiers.
Methods: Forty-six Swedish adult skiers competing at national or international level were
included. They had a mean (SD) training volume in the past 12 months of 593 (122) hours.
Twenty-four subjects had previous physician-diagnosed asthma. The European Community Respi-
ratory Health Survey questionnaire was used to evaluate the presence of respiratory symptoms.
BHRwasdefinedasbronchoconstriction to either eucapnic voluntary hyperventilation, drypowder
mannitol or methacholine provocation.
Results: The “classical” EIA symptom of shortness of breath post-exercise was reported by 17% of
all skiers. Eight subjects (17%) had BHR. None of the self-reported respiratory symptoms had high
positive predictive values. However, symptoms caused by grass or pollen had high negative predic-
tive values.
Discussion: EIA in elitewinter athletes cannot accurately be basedonly on self-reported symptoms
but requires verificationwith objective testingofBHR. Bronchoprovocationofelitewinter athletes
reporting respiratory symptoms in rest orbecauseofexercisewill probably reveal ahighproportion
of athletes without BHR.
Clinical trial: EUDRA-CT number 2006-005822-21.
ª 2010 Elsevier Ltd. All rights reserved.e and Allergy, O¨stersund Hospital, 83183 O¨stersund, Sweden. Tel.:þ46 63 153000; fax:þ46 63 154524.
ll.se.
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Respiratory symptoms in relationship to exercise, bron-
chial hyperresponsiveness (BHR), and exercise-induced
asthma (EIA) are very common in elite athletes. The
diagnosis of EIA requires a combination of symptoms and
objective criteria such as positive exercise test, positive
bronchodilator test or the presence of BHR to direct or
indirect stimuli.1
Guidance on whom to screen for EIA would be valuable.
Unfortunately, among athletes in general, respiratory
symptoms questionnaires have shown low diagnostic accu-
racy as screening tools for BHR.2e5 The usefulness of
symptom questionnaires to identify BHR in elite winter
athletes is still unclear. In high-school cross-country skiers,
Ogston et al. found a high correlation between a history of
missing work or school as a result of chest tightness, cough,
wheezing, or prolonged shortness of breath post-exercise
and post-exercise bronchoconstriction.6
Theaimof thepresent studywas toevaluate thediagnostic
accuracy of self-reported symptoms as predictors of BHR in an
unselected population of adult elite winter athletes.
Material and methods
Subjects
Swedish athletes aged 18 years and over and competing in
cross-country skiing or biathlon at national or international
level were eligible for participation in the study. Study invi-
tations were sent to skiers and coaches at the Skiing
University and the Swedish National Winter Sports Research
Centre,Mid-SwedenUniversity, O¨stersund.Written informed
consent was obtained from each subject and the study was
approved by the Swedish Medical Products Agency and the
ethics committee at Umea˚ University, Sweden.
Forty-six subjects were included during April
2007eFebruary 2008, 22 were female and 24 male. The
median (range) age was 21 (19e31) years. They had a mean
(range) training volume in the past 12 months of 593
(200e800) hours (Table 1).
Methods
The study was carried out at the Department of Respiratory
Medicine and Allergy, O¨stersund Hospital, O¨stersund and
the Swedish National Winter Sports Research Centre, Mid-
Sweden University, O¨stersund.
There were three study days. On day 1, subjects
completed a shortened version of the European Community
Respiratory Health Survey II (ECRHS II) main questionnaire,7
underwent a medical history, and physical examination
with venepuncture. Bronchial provocation with eucapnic
voluntary hyperventilation (EVH), dry powder mannitol or
methacholine was performed in randomized order on each
study day, with an interval of 2e7 days between
challenges.
Lung function was assessed by spirometry using the
Spirare 3 spirometer (Diagnostica, Oslo, Norway).8,9 BHR
was defined as positive test to either EVH, mannitol or
methacholine provocation. Before each challenge, thesubjects had to be free of airway infection for at least 2
weeks. They had to refrain from short-acting b2-agonists
for 8 h, inhaled corticosteroids and short-acting anticho-
linergics for 12 h, long-acting b2-agonists and theophylline
for 24 h, ipatropium and antihistamines for 72 h and
leukotriene receptor antagonists for 4 days. They were
asked to refrain from consumption of coffein-containing
beverages as well as from physical training on the day of
the challenge.
During EVH subjects inhaled dry medical air (Carboair,
Air Liquide, Malmo¨, Sweden).10 The air was delivered
using a commercially available device (Aiolos Astmatest,
Aiolos Medical AB, Karlstad, Sweden). The target venti-
lation was set at baseline forced expiratory volume first
second (FEV1)  30 L/min, giving approximately 85% of
predicted maximal voluntary ventilation. FEV1 was
measured immediately before and at 3, 5, 7, 10, 15 and
20 min post-EVH. A decrease of FEV110% sustained over
at least two consecutive time-points was considered to be
a positive test.
Mannitol provocation was performed according to
a standard protocol using Aridol (Pharmaxis, Australia).
The dose protocol consisted of inhalation of 0, 5, 10, 20, 40,
80, 160, 160 and 160 mg mannitol dry powder. A provoca-
tive dose causing a reduction of FEV1 by 15% (PD15 FEV1) of
635 mg was considered to be a positive test.11
Methacholine challengewas performed using a controlled
tidal volume breathing technique and the Spira Elektro 2
automatic inhalation synchronized dosimeter jet nebulizer
(Respiratory Care Centre, Ha¨meenlinna, Finland).12 Meth-
acholinewas delivered in six cumulative doses of 40, 81, 183,
386, 794 and 1812 mg. A PD20 FEV1 of1812 mgmethacholine
was considered to be a positive test.
Serum was examined by UniCAP RAST Phadiatop
(Pharmacia Diagnostics, Uppsala, Sweden) for the presence
of specific IgE to house dust mite, Penicillium, Cladospo-
rium, Aspergillus and Alternaria, cat, horse, dog, timothy
grass, birch and mugwort. A specific IgE concentration of at
least 0.35 kUA/L was considered to be evidence of allergic
sensitisation.
Statistics
R: A language and environment for statistical computing,
version 2.9.2 was used for statistical analyses.13 The
screening questions were combined to produce a “contin-
uous asthma score” of 0e8. A positive answer to any one of
the questions gave the score “1”, a positive answer to any
two of the questions gave a score of “2”, and so on.
Results
Eight subjects (17%) responded to one or several bronchial
challenges (Table 1). The classical EIA symptom “shortness
of breath post-exercise” was reported by 17% of all skiers
(Table 2).
A selection of questions with relatively high diagnostic
accuracy is presented in Table 2. None of the self-reported
symptoms had high positive predictive values as screening
tools for BHR. Self-reported shortness of breath post-
exercise had a poor diagnostic accuracy in the study
Table 1 The study population of 46 Swedish elite cross-country skiers.
Healthy Physician-diagnosed asthma P-value
FVC, Liters 5.5 (0.9) 4.7 (1.1) 0.01
FVC, % of predicted 99.6 (10.1) 95.5 (13.7) 0.25
FEV1, Liters 4.5 (0.5) 4.0 (0.8) 0.02
FEV1, % of predicted 101.4 (7.5) 97.7 (14.0) 0.27
EVH positive, n (%) 3 (14) 3 (12) 0.91
Mannitol positive, n (%) 1 (5) 2 (8) 0.60
Methacholine positive, n (%) 0 (0) 2 (8) 0.17
EVH, mannitol and/or methacholine positive, n (%) 3 (14) 5 (21) 0.52
Serum specific IgE >0.35 kUA/L (%) 55 50 0.77
Lung volumes presented as mean (SD), FVCZ forced vital capacity, FEV1Z forced expiratory volume first second, P-values by Student’s
t test (means) and Pearson Chi-square (proportions).
1762 N. Stenforspopulation. However, symptoms from grass or pollen had
a very high negative predictive value (Table 2).
Combining the questions reported in Table 2 into a contin-
uous asthma score did not increase the diagnostic accuracy.
An increase in the “continuous asthma score” was not asso-
ciated with an increase in the prevalence of BHR (Fig. 1).Table 2 Self-reported symptoms as predictors of bronchial h
country skiers.
Prevalence
%
Sensi
% (95
Have you had wheezing or whistling in
your chest at any time in
the last 12 months?
Have you been at all breathless
when the wheezing noise was present?
37 62 (2
Have you woken up with a feeling
of tightness in your chest at
any time in the last 12 months?
7 12 (0
Have you had an attack of shortness of
breath that came on
during the day when you
were at rest at any time in
the last 12 months?
4 12 (0
Have you had an attack of shortness
of breath that came on
following strenuous activity
at any time in the last 12 months?
17 25 (3
When you are near trees, grass or flowers,
or when there is a lot of pollen about,
do you ever start to cough, start
to wheeze, get a feeling of tightness
in your chest, start to feel short of breath,
get a runny or stuffy nose or start to
sneeze or get itchy or watering eyes?
52 88 (4
Have you ever had asthma
confirmed by a doctor?
52 62 (2
Have you had an attack of asthma
in the last 12 months?
15 12 (0
Are you currently taking any medicines
including inhalers, aesosols and
tablets for asthma
37 38 (9
CI Z Confidence interval, PPV Z Positive predictive value, NPV Z NDiscussion
The present study found that the respiratory symptoms
questionnaire ECHRS II had poor diagnostic accuracy as
a screening tool for BHR in an unselected population of
adult elite cross-country skiers. However, the absence ofyperresponsiveness in 46 healthy and asthmatic elite cross-
tivity
% CI)
Specificity %
(95% CI)
PPV %
(95% CI)
NPV %
(95% CI)
DA %
(95% CI)
4e91) 68 (51e82) 29 (10e56) 90 (73e98) 67 (52e80)
e53) 95 (82e99) 33 (0e91) 84 (69e93) 80 (66e91)
e53) 97 (86e100) 50 (1e98) 84 (70e93) 83 (69e92)
e65) 84 (69e94) 25 (3e65) 84 (69e94) 74 (59e86)
7e100) 55 (38e71) 29 (13e51) 95 (77e100) 61 (45e75)
4e91) 50 (33e67) 21 (7e42) 86 (65e97) 52 (37e67)
e53) 84 (69-949 14 (0e58) 82 (66e92) 72 (57e84)
e76) 63 (46e78) 18 (4e43) 83 (64e94) 59 (43e73)
egative predictive value, DA Z Diagnostic accuracy.
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Figure 1 Prevalence of subjects with a given number of
airway symptoms and the prevalence of bronchial hyper-
responsiveness (BHR).
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tive values.
There are some limitations in the study that should be
taken into account. Firstly, the numbers of study subjects
and the prevalence of BHR were relatively low, leading to
some imprecision in the results. Secondly, the asthmatic
athletes were probably biased towards subjects with mild
and/or well-controlled asthma, as only 21% of them had BHR
and 29% had experienced shortness of breath post-exercise
in the last 12 months. The prevalent use of anti-inflamma-
tory treatment in this group had probably decreased their
bronchial responsiveness.
Like previous studies on mostly summer sport
athletes,2e5 the present study found that airway symptoms
in elite winter sport athletes are present irrespective of
concurrent BHR. Also, the present results give no support to
assumptions that the probability of BHR in winter sport
athletes increases in conjunction with increasing airway
symptoms. The absence of distinct correlation between
respiratory symptoms and BHR may be due to the fact that
both have temporal variability. Most subjects were tested
outside the competitive season, and BHR has been shown to
be influenced by training intensity, environment and
seasonal variation.14,15
In contrast to the findings of Ogston et al., the present
study did not find that previous physician-diagnosed asthma
accurately predicted the presence of BHR. Notably, Ogston
studied adolescents and had fewer athletes with, or on
treatment for, EIA/asthma.6
However, it is possible that study results would differ in
a population of winter athletes with a higher prevalence of
BHR or with more severe asthma/EIA. The recent recom-
mendation by ERS, EAACI and GA2LEN1 e that symptoms
such as wheeze, cough, heavy breathing, that occur either
spontaneously or because of physical exercise in athletes
should lead to the necessary follow-up with adequate
objective measures will probably lead to bronchoprovoca-
tion of many subjects without BHR among elite cross-
country skiers.
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